National Institute of Child Health and Human Development, Notice of Closed Meeting, 29774-29775 [05-10331]

Download as PDF 29774 Federal Register / Vol. 70, No. 99 / Tuesday, May 24, 2005 / Notices individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Lithium for the Treatment of Pediatric Mania. Date: June 13, 2005. Time: 1:30 p.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20817. Contact Person: Kishena C. Wadhwani, PHD, MPH, Scientific Review Administrator, Division of Scientific Review, 9000 Rockville Pike, MSC 7510, 6100 Building, Room 5B01, Bethesda, MD 20892–7510, (301) 496–1485, wadhwank@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10328 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Concept Clearance Review Acute Respiratory Disorder of the Newborn and its Relationship to Group B Streptococcal Colonization. Date: June 10, 2005. Time: 12 p.m. to 2 p.m. Agenda: To review and evaluate contract proposals. VerDate jul<14>2003 17:36 May 23, 2005 Jkt 205001 Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Hameed Khan, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 435–6902, khanh@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10329 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Dental and Craniofacial Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Dental and Craniofacial Research Council. Date: June 10, 2005. Open: 8:30 a.m. to 2 p.m. Agenda: Director’s Report, Working Group Reports, Concept Clearance, Training Conference Report. PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892. Closed: 2 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892. Contact Person: Norman S Braveman, PhD, Assistant to the Director, NIH–NIDCR, Building 31, Rm. 5B55, Bethesda, MD 20892, (301) 594–2089, Norman.Braveman@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contract Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nidcr.nih.gov/about, where an agenda and any additional information for the meeting will be posed when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10330 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development, Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Azithromycin for BPD. Date: June 13, 2005. Time: 8:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\24MYN1.SGM 24MYN1 Federal Register / Vol. 70, No. 99 / Tuesday, May 24, 2005 / Notices Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20817. Contact Person: Kishena C. Wadhwani, PhD, MPH, Scientific Review Administrator, Division of Scientific Review, 9000 Rockville Pike, MSC 7510, 6100 Building, Room 5B01, Bethesda, MD 20892–7510, (301) 496– 1485,wadhwank@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS.) Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10331 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M NW., Washington, DC 20037. The meeting date and time remain the same. The meeting is closed to the public. Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10320 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Coast Guard DEPARTMENT OF TRANSPORTATION Maritime Administration [USCG–2005–21232] DEPARTMENT OF HEALTH AND HUMAN SERVICES Beacon Port LLC, Liquefied Natural Gas Deepwater Port License Application National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Gastrointestinal Mucosal Pathobiology Study Section, June 6, 2005, 9 a.m. to June 7, 2005, 5 p.m. Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814 which was published in the Federal Register on May 11, 2005, 70 FR 24829–24832. The meeting will be held June 5, 2005, 6 p.m. to June 6, 2005, 5 p.m. The location remains the same. The meeting is closed to the public. Dated: May 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10319 Filed 5–23–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 13, 2005, 8 a.m. to June 13, 2005, 5 p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015, which was published in the Federal Register on May 11, 2005, 79 FR 24829–24832. The meeting will be held at The Watergate Hotel, 2650 Virginia Avenue, VerDate jul<14>2003 17:36 May 23, 2005 Jkt 205001 Coast Guard, DHS; Maritime Administration, DOT. ACTION: Notice of application. AGENCY: SUMMARY: The Coast Guard and the Maritime Administration (MARAD) announce that they have received an application for the licensing of a natural gas deepwater port, and that the application appears to contain the required information. This notice summarizes the applicant’s plans and the procedures that will be followed in considering the application. DATES: The Deepwater Port Act of 1974, as amended, requires any public hearing on this application to be held not later than January 19, 2006, and requires a decision on the application to be made not later than April 19, 2006. ADDRESSES: The public docket for USCG–2005–21232 is maintained by the: Docket Management Facility, U.S. Department of Transportation, 400 Seventh Street, SW., Washington, DC 20590–0001. Docket contents are available for public inspection and copying, at this address, in room PL–401, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The Facility’s telephone is 202–366–9329, its fax is 202–493–2251, and its Web site for electronic submissions or for electronic access to docket contents is https://dms.dot.gov. FOR FURTHER INFORMATION CONTACT: Lieutenant Commander Kevin Tone, U.S. Coast Guard, telephone: 202–267– 0226, e-mail: KTone@comdt.uscg.mil. If you have questions on viewing the docket, call Andrea M. Jenkins, Program PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 29775 Manager, Docket Operations, telephone: 202–366–0271. SUPPLEMENTARY INFORMATION: Receipt of application On January 18, 2005, the Coast Guard and MARAD received an application from Beacon Port LLC, 600 N. Dairy Ashford, Houston, TX 77079–1175 for all Federal authorizations required for a license to own, construct, and operate a deepwater port governed by the Deepwater Port Act of 1974, as amended, 33 U.S.C. 1501 et seq. (the Act). A portion of the original submission did not contain sufficient information. On April 16, 2005, we received revised information which enabled us to complete our review. On May 10, 2005, we determined that the application appeared to contain all information required by the Act. Background According to the Act, a deepwater port is a fixed or floating manmade structure other than a vessel, or a group of structures, located beyond State seaward boundaries and used or intended for use as a port or terminal for the transportation, storage, and further handling of oil or natural gas for transportation to any State. A deepwater port must be licensed by the Secretary of Transportation. Statutory and regulatory requirements for licensing appear in 33 U.S.C. 1501 et seq. and in 33 CFR Part 148. Under delegations from and agreements between the Secretary of Transportation and the Secretary of Homeland Security, applications are processed by the Coast Guard and MARAD. Each application is considered on its merits. The Act provides strict deadlines for processing an application. Once a notice is published indicating that an application appears to contain the required information, we must hold public hearings on the application within 240 days, and the Secretary of Transportation must render a decision on the application within 330 days. We will publish additional Federal Register notices to inform you of these public hearings and other procedural milestones, including environmental review. The Secretary’s decision, and other key documents, will be filed in the public docket. At least one public hearing must take place in each adjacent coastal State. For purposes of the Act, Louisiana and Texas are the adjacent coastal States for this application. Other States can apply for adjacent coastal State status in accordance with 33 U.S.C. 1508(a)(2). E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 70, Number 99 (Tuesday, May 24, 2005)]
[Notices]
[Pages 29774-29775]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10331]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development, Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Azithromycin for BPD.
    Date: June 13, 2005.
    Time: 8:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 29775]]

    Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, 
MD 20817.
    Contact Person: Kishena C. Wadhwani, PhD, MPH, Scientific Review 
Administrator, Division of Scientific Review, 9000 Rockville Pike, 
MSC 7510, 6100 Building, Room 5B01, Bethesda, MD 20892-7510, (301) 
496-1485,wadhwank@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS.)

    Dated: May 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10331 Filed 5-23-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.